PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378709
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378709
The global orthopedic biomaterial market is estimated to be valued at US$ 15.7 Bn in 2023, and is expected to exhibit a CAGR of 9.9% during the forecast period (2023-2030).
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 15.7 Bn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 9.90% | 2030 Value Projection: | US$ 30.5 Bn |
Biomaterials are broadly used in medical procedures, such as orthopedics. Orthopedic biomaterials are derived from organic or synthetic materials that help in the restoration of the structural integrity of bones that are damaged due to trauma or disease. Orthopedic biomaterials are incorporated into the human body as part of devices designed to perform certain biological functions by substituting or repairing various tissues, such as ligaments, cartilage, bones, tendons, and others. The application sectors of the product include joint replacement, spine implants, orthobiologics, viscosupplementation, and bio-resorbable tissue fixation. Some key characteristics and types of orthopedic biomaterials include biocompatibility, wear resistance, corrosion resistance, and others. One of the key characteristics of orthopedic biomaterials is their biocompatibility. This means that these materials are designed to work in harmony with the human body without causing any adverse reactions. This is particularly important as these materials are often incorporated into the body as part of medical devices.Another important characteristic of orthopedic biomaterials is their wear resistance. Given that these materials are often used in joint replacements and other procedures that involve constant movement, it's crucial that they can withstand the wear and tear of daily activities. This ensures the longevity of the medical devices in which they are used.Corrosion resistance is another key feature of orthopedic biomaterials. This ensures that the biomaterials do not degrade or break down over time, which could potentially lead to complications.
The orthopedic biomaterial market is expected to witness significant growth owing to increasing aging population, technological advancements, increasing product launches or approvals by market players, and others. For instance, in March 2023, Invibio Biomaterial Solutions, a division of Victrex plc and a pioneer in the development of PEEK biomaterial solutions, announced the launch of PEEK-OPTIMA AM Filament, an implantable PEEK polymer optimized for additive manufacturing. PEEK (Polyetheretherketone) is a high-performance thermoplastic polymer with qualities that make it appropriate for orthopedic and spinal implant applications.
The new PEEK-OPTIMA AM filament increases Invibio's line of biocompatible polymers, which are currently available in powders, granules, and rods for injection molding and other processing processes. PEEK-OPTIMA is often utilized in orthopedic and spinal implant applications such as in spinal fusion surgery, as well as different components used in joint replacement treatments.
Key features of the study: